These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10478702)

  • 1. Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists.
    Messerli FH
    Am J Hypertens; 1999 Aug; 12(8 Pt 2):86S-90S. PubMed ID: 10478702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined heart protection for the hypertensive patient].
    MMW Fortschr Med; 2013 Jan; 155(1):66-7. PubMed ID: 23573728
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ACE inhibitors and calcium antagonists: a logical approach.
    Ruschitzka FT; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S5-16. PubMed ID: 9605596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of combination therapy in hypertension.
    Messerli FH; Chander K
    J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S17-22. PubMed ID: 10854047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy.
    Epstein M
    Ren Fail; 1996 Nov; 18(6):813-32. PubMed ID: 8948517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed dose combinations of ACE inhibitors.
    Rangoonwala B; Schulz W; Bauer B
    Br J Clin Pract; 1996 Dec; 50(8):454-65. PubMed ID: 9039718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Osswald H; Mühlbauer B
    J Hypertens Suppl; 1995 Aug; 13(2):S21-8. PubMed ID: 8576784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 13. Diuretics in the prevention and treatment of congestive heart failure.
    Moser M
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():273-7. PubMed ID: 9211020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same?
    Smith DH
    Am J Cardiovasc Drugs; 2007; 7(6):413-22. PubMed ID: 18076208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
    Neutel JM; Smith DH; Weber MA
    Am J Hypertens; 2004 Jan; 17(1):37-42. PubMed ID: 14700510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination drug therapy in hypertension].
    Tsukiyama H; Shigemasa T; Ikoma E
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():596-602. PubMed ID: 15171443
    [No Abstract]   [Full Text] [Related]  

  • 20. Disparate effects of ACE-inhibitors and calcium antagonists on left ventricular structure and function in essential hypertension.
    Aepfelbacher FC; Messerli FH; Nunez E; Frohlich ED
    J Hum Hypertens; 1997 May; 11(5):321-5. PubMed ID: 9205940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.